Literature DB >> 11440772

Psychiatric symptoms and CAG repeats in neurologically asymptomatic Huntington's disease gene carriers.

G E Berrios1, A C Wagle, I S Marková, S A Wagle, L W Ho, D C Rubinsztein, J Whittaker, C Ffrench-Constant, A Kershaw, A Rosser, T Bak, J R Hodges.   

Abstract

The putative relationship between the psychiatric profile of a sample of neurologically asymptomatic Huntington's disease gene carriers and CAG repeats was investigated. The psychiatric assessments (by consultant psychiatrist and computerised battery) were undertaken before the genetic testing was carried out. In this way, the informational distortions caused by neurological and cognitive deficits were avoided. The hypothesis that there is a relationship between psychiatric and CAG repeats was tested by seeking direct correlations between psychiatric systems and CAG repeats, and also by correcting the correlation by the number of years above or below the estimated age of onset in Huntington's disease. Scores for irritability and cognitive failures were high in the sample. There was no correlation between any psychiatric variable and CAG repeats. Possible explanations for this lack of correlations are discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11440772     DOI: 10.1016/s0165-1781(01)00257-8

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  21 in total

1.  Suicidal ideation in Huntington disease: the role of comorbidity.

Authors:  Heather H Wetzel; Carissa R Gehl; Lisa Dellefave-Castillo; Judith F Schiffman; Kathleen M Shannon; Jane S Paulsen
Journal:  Psychiatry Res       Date:  2011-05-24       Impact factor: 3.222

2.  Depressive symptoms in prodromal Huntington's Disease correlate with Stroop-interference related functional connectivity in the ventromedial prefrontal cortex.

Authors:  Paul G Unschuld; Suresh E Joel; James J Pekar; Sarah A Reading; Kenichi Oishi; Julie McEntee; Megan Shanahan; Arnold Bakker; Russell L Margolis; Susan S Bassett; Adam Rosenblatt; Susumu Mori; Peter C van Zijl; Christopher A Ross; Graham W Redgrave
Journal:  Psychiatry Res       Date:  2012-09-11       Impact factor: 3.222

Review 3.  Progress in developing transgenic monkey model for Huntington's disease.

Authors:  Brooke R Snyder; Anthony W S Chan
Journal:  J Neural Transm (Vienna)       Date:  2017-11-10       Impact factor: 3.575

4.  Characterization of depression in prodromal Huntington disease in the neurobiological predictors of HD (PREDICT-HD) study.

Authors:  Eric A Epping; James A Mills; Leigh J Beglinger; Jess G Fiedorowicz; David Craufurd; Megan M Smith; Mark Groves; Kelly R Bijanki; Nancy Downing; Janet K Williams; Jeffrey D Long; Jane S Paulsen
Journal:  J Psychiatr Res       Date:  2013-06-19       Impact factor: 4.791

5.  Deficits in experience-dependent cortical plasticity and sensory-discrimination learning in presymptomatic Huntington's disease mice.

Authors:  Nektarios K Mazarakis; Anita Cybulska-Klosowicz; Helen Grote; Terence Pang; Anton Van Dellen; Malgorzata Kossut; Colin Blakemore; Anthony J Hannan
Journal:  J Neurosci       Date:  2005-03-23       Impact factor: 6.167

Review 6.  Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function.

Authors:  L A Raymond; V M André; C Cepeda; C M Gladding; A J Milnerwood; M S Levine
Journal:  Neuroscience       Date:  2011-08-27       Impact factor: 3.590

7.  Timing and Impact of Psychiatric, Cognitive, and Motor Abnormalities in Huntington Disease.

Authors:  Branduff McAllister; James F Gusella; G Bernhard Landwehrmeyer; Jong-Min Lee; Marcy E MacDonald; Michael Orth; Anne E Rosser; Nigel M Williams; Peter Holmans; Lesley Jones; Thomas H Massey
Journal:  Neurology       Date:  2021-03-25       Impact factor: 11.800

8.  Smaller intracranial volume in prodromal Huntington's disease: evidence for abnormal neurodevelopment.

Authors:  Peggy C Nopoulos; Elizabeth H Aylward; Christopher A Ross; James A Mills; Douglas R Langbehn; Hans J Johnson; Vincent A Magnotta; Ronald K Pierson; Leigh J Beglinger; Martha A Nance; Roger A Barker; Jane S Paulsen
Journal:  Brain       Date:  2010-10-04       Impact factor: 13.501

9.  A pilot assessment of parental practices and attitudes regarding risk disclosure and clinical research involving children in Huntington disease families.

Authors:  Leon S Dure; Kimberly Quaid; T Mark Beasley
Journal:  Genet Med       Date:  2008-11       Impact factor: 8.822

10.  Selective roles of normal and mutant huntingtin in neural induction and early neurogenesis.

Authors:  Giang D Nguyen; Solen Gokhan; Aldrin E Molero; Mark F Mehler
Journal:  PLoS One       Date:  2013-05-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.